PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines
Oncotarget (2017) - Comments
pubmed: 28390196  doi: 10.18632/oncotarget.15542  issn: 1949-2553 

Simona Ultimo, Carolina Simioni, Alberto M. Martelli, Giorgio Zauli, Camilla Evangelisti, Claudio Celeghini, James A. McCubrey, Giorgia Marisi, Paola Ulivi, Silvano Capitani, Luca M. Neri